Core Labs cuts Q1 2026 guidance citing Middle East conflict; revenue now $119-123M

Core Laboratories Inc. /DE/

First quarter 2026 revenue guidance revised to $119M-$123M, down from previously issued guidance.
Operating income ex-items projected at $5.7M-$7.1M; EPS ex-items $0.05-$0.07.
Client-driven project delays, travel constraints, and supply-chain disruptions from Middle East conflict cited.
Reservoir Description segment most impacted; Production Enhancement less affected but energetics shipments delayed.
Earnings call scheduled for April 30, 2026; press release on April 29 after market close.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.